Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro

BACKGROUND: Estrogen receptor β (ERβ) is expressed in the majority of invasive breast cancer cases, irrespective of their subtype, including triple-negative breast cancer (TNBC). Thus, ERβ might be a potential target for therapy of this challenging cancer type. In this in vitro study, we examined th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Schüler-Toprak, Susanne, Häring, Julia, Inwald, Elisabeth C., Moehle, Christoph, Ortmann, Olaf, Treeck, Oliver
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5178087/
https://ncbi.nlm.nih.gov/pubmed/28003019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2973-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk